Dissertations / Theses on the topic 'Clinical Sciences'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 dissertations / theses for your research on the topic 'Clinical Sciences.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Cai, Yan. "Clinical and pre-clinical pharmacokinetics of green tea polyphenols." Diss., The University of Arizona, 2002. http://hdl.handle.net/10150/280157.
Full textCampanile, Loredana. "Effective clinical instruction : selection of behaviours by occupational therapy clinical supervisors." Thesis, McGill University, 1992. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=56962.
Full textDoby, Cynthia Funnye. "Awareness of Clinical Laboratory Sciences and Shortage of Clinical Laboratory Scientists in the 21st Century." ScholarWorks, 2016. https://scholarworks.waldenu.edu/dissertations/3095.
Full textMehrabi, Saeed. "Advanced natural language processing and temporal mining for clinical discovery." Thesis, Indiana University - Purdue University Indianapolis, 2016. http://pqdtopen.proquest.com/#viewpdf?dispub=10032405.
Full textThere has been vast and growing amount of healthcare data especially with the rapid adoption of electronic health records (EHRs) as a result of the HITECH act of 2009. It is estimated that around 80% of the clinical information resides in the unstructured narrative of an EHR. Recently, natural language processing (NLP) techniques have offered opportunities to extract information from unstructured clinical texts needed for various clinical applications. A popular method for enabling secondary uses of EHRs is information or concept extraction, a subtask of NLP that seeks to locate and classify elements within text based on the context. Extraction of clinical concepts without considering the context has many complications, including inaccurate diagnosis of patients and contamination of study cohorts. Identifying the negation status and whether a clinical concept belongs to patients or his family members are two of the challenges faced in context detection. A negation algorithm called Dependency Parser Negation (DEEPEN) has been developed in this research study by taking into account the dependency relationship between negation words and concepts within a sentence using the Stanford Dependency Parser. The study results demonstrate that DEEPEN, can reduce the number of incorrect negation assignment for patients with positive findings, and therefore improve the identification of patients with the target clinical findings in EHRs. Additionally, an NLP system consisting of section segmentation and relation discovery was developed to identify patients’ family history. To assess the generalizability of the negation and family history algorithm, data from a different clinical institution was used in both algorithm evaluations. The temporal dimension of extracted information from clinical records representing the trajectory of disease progression in patients was also studied in this project. Clinical data of patients who lived in Olmsted County (Rochester, MN) during 1966 to 2010 was analyzed in this work. The patient records were modeled by diagnosis matrices with clinical events as rows and their temporal information as columns. Deep learning algorithm was used to find common temporal patterns within these diagnosis matrices.
Cao, Xinyuan. "Assessment of Clinical Engineering Departments in developing countries." Thesis, University of Ottawa (Canada), 2004. http://hdl.handle.net/10393/26594.
Full textBrown, Sarah E. "Electromyographical Analysis of Barefoot Squat: A Clinical Perspective." Digital Commons @ East Tennessee State University, 2013. https://dc.etsu.edu/honors/58.
Full textRosenthal, Daniel Todd. "A clinician-mediated, longitudinal tracking system for the follow-up of clinical results." Thesis, Massachusetts Institute of Technology, 2005. http://hdl.handle.net/1721.1/33084.
Full textIncludes bibliographical references (p. 36-37).
Failure to follow-up on abnormal tests is a common clinical concern comprising the quality of care. Although many clinicians track their patient follow-up by scheduling follow-up visits or by leaving physical reminders, most feel that automated, computerized systems to track abnormal test results would be useful. While existing clinical decision support systems and computerized clinical reminders focus on providing assistance with choosing the appropriate follow-up management, they fail by not tracking that follow-up effectively. We believe that clinicians do not want suggestions how to manage their patients, but instead want help tracking follow-up results once they have decided the management plan. We believe that a well-designed system can successfully track this follow-up and only require a small amount of information and time from the clinician. We have designed and implemented a complete tracking system including 1) an authoring tool to define tracking guidelines, 2) a query tool to search electronic medical records and identify patients without follow-up, and 3) a clinical tool to send reminders to clinicians and allow them to easily choose the follow-up management. Our tracking system has made improvements on previous reminder systems by 1) using our unique risk-management guideline model that more closely mirrors, yet does not attempt to replicate, the clinical decision process, 2) our use of massive population-based queries for tracking all patients simultaneously, and 3) our longitudinal approach that documents all steps in the patient follow-up cycle. With these developments, we are able to track 450 million pieces of clinical data for 1.8 million patients daily.
(cont.) Keyword follow-up tracking; reminder system; preventive medicine; computerized medical record system; practice guidelines; clinical decision support system
by Daniel Todd Rosenthal.
S.M.
Carberry, Helen. "Semiotic analysis of clinical chemistry: for "knowledge work" in the medical sciences." Thesis, Queensland University of Technology, 2003. https://eprints.qut.edu.au/15809/1/Helen_Carberry_Thesis.pdf.
Full textCarberry, Helen. "Semiotic analysis of clinical chemistry: for " knowledge work " in the medical sciences." Queensland University of Technology, 2003. http://eprints.qut.edu.au/15809/.
Full textMorley, Michelle. "Simulation and baccalaureate nursing students' clinical competence." Thesis, University of Ottawa (Canada), 2007. http://hdl.handle.net/10393/27893.
Full textRahman, Najib. "Clinical trials in pleural disease." Thesis, University of Oxford, 2011. http://ora.ox.ac.uk/objects/uuid:930991f1-3424-4b96-984e-06df7f6e9204.
Full textSmith, Laurie Ann Johnson. "Clinical decision making capacity among institutionalized elders." Thesis, The University of Arizona, 1993. http://hdl.handle.net/10150/278392.
Full textEgermayer, Paul Charles. "The epidemiology and clinical pathophysiology of thromboembolic disease." Thesis, University of Auckland, 2001. http://wwwlib.umi.com/dissertations/fullcit/3085722.
Full textSubscription resource available via Digital Dissertations only.
Louie, Tiffany M. "Clinical assessment of early demineralization using PS-OCT." Diss., Search in ProQuest Dissertations & Theses. UC Only, 2009. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqdiss&rft_dat=xri:pqdiss:1465486.
Full textRodella, Stefania. "Exploring reliability in epidemiology and clinical research." Thesis, McGill University, 1996. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=23421.
Full textReliability indices are frequently used and presented in the medical literature and a considerable amount of methodological research has been conducted on this topic in the last decades. However, the debate is still open on some theoretical and operational aspects. Available knowledge concerning reliability, particularly for categorical data, is not easily accessible since it is often confined to specialized journals and almost disregarded by statistical textbooks. Therefore, a thorough understanding is difficult to achieve for a researcher potentially involved in reliability studies.
My main objective was to pursue a conceptual and global understanding of the role of reliability in the domain of categorical data. In order to achieve this goal I reviewed and synthesized the literature according to some specific objectives: (a) to provide an overview on the founding concepts and methods in the measurement of reliability for categorical variables, also contrasting them with what has been done in the domain of continuous variables; (b) to present and discuss the main limitations of traditional indices, particularly the kappa statistic; (c) to briefly introduce some possible alternative methods and areas for future development; (d) to emphasize the implications of reliability for epidemiological and clinical research.
Finally, in order to illustrate the application of some of the methods discussed, I used a real set of data, concerning 209 slides of lymphomas tissue samples, reviewed by a panel of four pathologists, according to a standard classification based on 10 categories.
Ostrovska, Alexsandra. "Vestibular evoked myogenic potentials in clinical applications." Thesis, McGill University, 2004. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=80345.
Full textHorowitz, Roberta S. "Idea Analysis for the Development of Clinical Trial Strategies." NSUWorks, 1995. http://nsuworks.nova.edu/gscis_etd/589.
Full textYee, Daphne. "Clinical epidemiology of mono-pyrazinamide-resistant Mycobacterium tuberculosis in Quebec." Thesis, McGill University, 2006. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=101809.
Full textWang, Chenchen 1958. "Clinical and health status of patients with Systemic Lupus Erythematosus : the impact of disease activity, damage and other clinical measures." Thesis, McGill University, 1999. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=29928.
Full textDisease activity was measured by the SLE Disease Activity Index (SLEDAI), Systemic Lupus Activity Measure (SLAM-2) and cumulative damage by the Systemic Lupus International Cooperating Clinics/ACR damage index (DI). Quality of life was assessed by the Medical Outcome Survey Short Form 36 (SF-36) and the Euroqol (EQ-5D) self-report questionnaires. Multiple linear regression was used to identify significant predictors of patients' self reported health status. Cumulative damage was found to be associated with physical function, physical health and social functioning (SF-36); disease activity was found to have a significant association with general health (SF-36) and a weaker association on overall health status as evaluated through the 'thermometer' rating scale of the EQ-5D. Patients' ratings of ability with usual activities was strongly related to overall physical health (SF-36) as well as the physical functioning and general health subscales of the SF-36. In addition, patients' ratings of anxiety and depression were strongly related to overall mental health status (SF-36).
In conclusion, physical health of SLE patients was associated with disease activity, disease damage, capacity for usual activity, and mobility.
Grady, Jesse Glennan. "BIOMECHANICAL AND MOLECULAR CHARACTERISTICS OF 'HYPERELASTOSIS CUTIS' IN QUARTER HORSES." MSSTATE, 2008. http://sun.library.msstate.edu/ETD-db/theses/available/etd-11052007-102632/.
Full textDoran, Pamela. "Clinical severity and familial risk in mood disorders." Thesis, McGill University, 2012. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=110606.
Full textContexte: Le trouble dépressif majeur (TDM) et le trouble bipolaire (TB) sont des maladies très répandues qui causent le fardeau substantiel dans la personne touchée, leurs familles, et dans la société en général. Ces conséquences soulignent l'importance de la recherche étiologique dans le but d'élaborer des mesures supérieures à la fois de prévention et de traitement. Bien que les antécédents familiaux est le facteur de risque le plus constamment répliqué pour les troubles de l'humeur, des efforts minimes ont été apporté à décrire les différences dans les caractéristiques sociodémographiques et cliniques entre les patients avec des formes familiales et non familiales de ces troubles. Par ailleurs, malgré l'absence de résultats convaincant dans les études d'association pangénomique et les études de liaison concernant les gènes impliqués dans l'étiologie des troubles de l'humeur, les enquêteurs n'ont pas encore examiné l'importance de l'exposition aux membres de la famille souffrant d'une maladie mentale en influençant l'apparition et l'évolution des troubles de l'humeur. Méthodes: Les sujets inclus 378 patients à l'externe avec un diagnostic DSM-IV de la TDM (N=139) ou TB (N=239). Examens rétrospectifs des dossiers ont été menées afin d'examiner les différences dans les caractéristiques sociodémographiques et cliniques entre les sujets avec et sans des antécédents familiaux rapportés par un médecin. Les antécédents familiaux rapportés par le patient ont été utilisés pour comparer des sujets sur plusieurs variables auto-déclarées sur l'exposition aux membres de la famille touchée. Les associations entre ces variables et les caractéristiques cliniques ont également été examinées.Résultats: Les sujets avec un trouble de l'humeur ayant des antécédents familiaux rapportés par un médecin étaient principalement anglais et née au Canada, et les sujets sans une telle histoire étaient pour la plupart au chômage. En termes de caractéristiques cliniques, les sujets avec des antécédents familiaux de TB rapportés par un médecin a demandé l'assistance psychiatrique à un plus jeune âge et les sujets avec un TDM sans une telle histoire ont été hospitalisés plus souvent. En ligne avec la recherche précédente, les sujets avec un TB ont démontré plus de membres de la famille touchée avec soit un TB ou bien de la schizophrénie/psychose par rapport aux sujets de TDM. De plus, des antécédents familiaux de schizophrénie/psychose et de problèmes de drogue ont été associés à des hospitalisations plus fréquentes. Enfin, des antécédents familiaux de problèmes de drogue et d'alcool ainsi que de vivre avec deux ou plusieurs membres de la famille gravement malades, ont été associés à plus de tentatives de suicide à vie. Conclusions: Les antécédents familiaux jouent indéniablement un rôle instrumental dans l'apparition et à la présentation clinique des troubles de l'humeur. Nos résultats met un accent particulier sur l'importance de l'exposition aux antécédents familiaux et leur capacité à fonctionner comme facteurs de risque, en combinaison d'une sous-jacente susceptibilité génétique, pour produire des cas plus graves et débilitantes de ces troubles. Les cliniciens devraient examiner soigneusement les antécédents familiaux de chaque patient, car cela peut ajouter de la valeur aux évaluations de risque pour les tentatives de suicide et les hospitalisations.
Polaha, Jodi, McKenzie Highsmith, William Lusenhop, Deepu George, and Adrian Sandoval. "Clinical Evaluators Take Your Mark." Digital Commons @ East Tennessee State University, 2019. https://dc.etsu.edu/etsu-works/6881.
Full textMcKerrell, Rosemary. "Labrador retriever myopathy : clinical and pathological investigation." Thesis, University of Cambridge, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.306555.
Full textCarlson, Robin. "Clinical Significance of Response Shift in a Spine Interventional Clinical Trial." ScholarWorks, 2015. https://scholarworks.waldenu.edu/dissertations/231.
Full textThiers, Fabio Albuquerque. "The globalization of clinical drug development." Thesis, Massachusetts Institute of Technology, 2006. http://hdl.handle.net/1721.1/35556.
Full textIncludes bibliographical references (p. 54-58).
Industry-sponsored clinical research of investigational drugs (also called clinical development) has traditionally been carried out in relatively developed countries in the North American, Western European, and Pacific regions. However, lately it has been widely reported that clinical trials starting now are becoming increasingly diffused globally, with significant growth of activity in so-called emerging economies in Eastern Europe, Latin America, and Southeast Asia. This change in location of clinical development activities has numerous implications for patients, health care providers, pharmaceutical companies, regulatory agencies and governments around the globe. Even though there is much debate about the topic, a public systematic quantitative assessment of the current status of the globalization of clinical drug development phenomenon is lacking. The objective of this thesis research is to provide such objective quantification while addressing some issues that are currently in active discussion. This thesis documents that the participation of emerging countries is still relatively small (13%) and they most commonly participate in very large (involving more than five countries) phase Ilb or III trials.
(cont.) Albeit perceived as small, this participation is growing at a rapid pace (23% average annual growth rate) and the number of clinical sites of global clinical trials located in all emerging countries (11,038) is comparable with the sum of Germany, France, U.K., and Italy (11,061). Eastern European and Latin American countries have the greatest participation in clinical trials among emerging countries, but Southeast Asia is the region that is experiencing fastest growth. Meanwhile, Western Europe has experienced negative average annual growth of -8%, and North America has seemingly been stable. This thesis discusses findings and key drivers behind the globalization process. I also consider the argument that the sustainability of this model will depend on stringent protection of patients in these emerging countries and continued development of these nations, with eventual creation of an attractive market for pharmaceutical products. The extension of this process of globalization of clinical trials, if coupled with substantial improvements in health care delivery and research capacity in these emerging economies, has the potential of revolutionizing medical product development within the next two decades.
by Fabio Albuquerque Thiers.
S.M.
Abdi, Yasin. "The appropriateness of clinical microbiology laboratory investigations : a retrospective study of the cost and clinical relevance of specimen management and processing." Thesis, University of Portsmouth, 2011. https://researchportal.port.ac.uk/portal/en/theses/the-appropriateness-of-clinical-microbiology-laboratory-investigations(b1f5faea-580b-4dad-b033-8ecc2407ff97).html.
Full textMac, Donald Tanya. "Standardized functional capacity outcome measures in post-operative cardiac surgery: A survey of current clinical practice and development of a clinical practice guideline (CPG)." Thesis, University of Ottawa (Canada), 2009. http://hdl.handle.net/10393/28369.
Full textGhanbari, Hedieh. "Predictors of temporomandibular disorders : clinical variables and patient characteristics." Thesis, McGill University, 2006. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=101127.
Full textIn addition, adjusted analysis among the DD patients showed an association with clenching-grinding, orthodontic treatment, and anxiety. Our results identify possible risk factors that are associated with TMD, MFP, and DD occurrence. Further research needs to be conducted to look at these associations in depth.
Taylor, Demetra T. "Investigation of a Clinical Suicide Risk Assessment." The Ohio State University, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=osu1408981316.
Full textMcAllister, Lindy. "The experience of being a clinical educator." Connect to full text, 2001. http://hdl.handle.net/2123/4017.
Full textTitle from title screen (viewed Jan. 22, 2009) Submitted in fulfilment of the requirements for the degree of Doctor of Philosophy to the School of Physiotherapy, Faculty of Health Sciences. Includes bibliography. Also available in print form.
Coleman-Ferreira, Kimberly W. "Achieving Competence: Clinical Instructors' Perspective." Diss., NSUWorks, 2015. https://nsuworks.nova.edu/hpd_pt_stuetd/1.
Full textLiu, Yun Ph D. Massachusetts Institute of Technology. "Applying domain knowledge to clinical predictive models." Thesis, Massachusetts Institute of Technology, 2016. http://hdl.handle.net/1721.1/104469.
Full textThis electronic version was submitted by the student author. The certified thesis is available in the Institute Archives and Special Collections.
Cataloged from student-submitted PDF version of thesis.
Includes bibliographical references (pages 115-124).
Clinical predictive models are useful in predicting a patient's risk of developing adverse outcomes and in guiding patient therapy. In this thesis, we explored two different ways to apply domain knowledge to improve clinical predictive models. We first applied knowledge about the heart to engineer better frequency-domain features from electrocardiograms (ECG). The standard frequency domain (in Hz) quantifies events that repeat with respect to time. However, this may be misleading because patients have different heart rates. We hypothesized that quantifying frequency with respective to heartbeats may adjust for these heart rate differences. We applied this beat-frequency to improve two existing ECG predictive models, one based on ECG morphology, and the other based on instantaneous heart rate. We then used machine learning to find predictive frequency bands. When evaluated on thousands of patients after an acute coronary syndrome, our method significantly improved prediction performance (e.g., area under curve, AUC, from 0.70 to 0.75). In addition, the same bands were found to be predictive in different patients for beat-frequency, but not for the standard frequency domain. Next, we developed a method to transfer knowledge from published biomedical articles to improve predictive models when training data are scarce. We used this knowledge to estimate the relevance of features to a given outcome, and used these estimates to improve feature selection. We applied our method to predict the onset of several cardiovascular diseases, using training data that contained only 50 adverse outcomes. Relative to a standard approach (which does not transfer knowledge), our method significantly improved the AUC from 0.66 to 0.70. In addition, our method selected 60% fewer features, improving interpretability of the model by experts, which is a key requirement for models to see real-world use.
by Yun Liu.
Ph. D. in Medical Engineering
Bennett, David M. "Effectiveness of clinical practice guidelines for treating asthma in the Department of Defense: A comparison of clinical and economic outcomes between the Army, Air Force, and Navy." Diss., The University of Arizona, 2002. http://hdl.handle.net/10150/280138.
Full textChoucair, Khalil. "The clinical implications of the survival pathway in prostate cancer." Thesis, McGill University, 2011. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=110572.
Full textLe cancer de la prostate (CaP) est la deuxième cause de décès par cancer chez les hommes nord-américains. L'hétérogénéité de la maladie, ainsi que l'imperfection des déterminants pronostiques actuels, constitue un défi pour les médecins qui sont incapables de distinguer les cancers indolents de ceux qui progresseront pour devenir mortels. Une étude antérieure a identifié 3 sous-types moléculaires de cancer de la prostate qui corrèlent avec le comportement clinique, et a rapporté une augmentation dans l'expression des gènes de la voie de signalisation PI/AKT dans les échantillons métastatiques, comparé aux cancers primaires. L'analyse des altérations génomiques dans ce groupe de patients a montré que l'amplification génomique 16p13 (PDPK1)et la délétion 10q23 (PTEN) sont fréquentes. PDK1 active la voie de survie PI /AKT, tandis que PTEN l'inhibe. Dans cette étude, nous rapportons pour la première fois la détection du gain génomique 16p13.3 (PDPK1) dans les métastases et de leurs échantillons appariés primaires, dans des spécimens de cancer de la prostate résistants à la castration, et dans des tumeurs primaire non-métastatiques. Le niveau de gain augmente dans les échantillons de stade avancé, soulignant ainsi une possible valeur pronostique. In vitro, nous avons caractérisé le rôle de PDK1 dans la motilité des cellules du cancer de la prostate, un processus essentiel à la métastase. Cette constatation appuie l'idée d'un rôle joué par le gain génomique 16p13 (PDPK1) dans la progression du cancer de la prostate vers une maladie létale, et rend PDK1 une cible thérapeutique potentielle chez les patients avec un cancer agressif.
Federico, Carole. "The characterization of preclinical evidence for agents entering clinical development." Thesis, McGill University, 2013. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=117175.
Full textLa traduction des découvertes biologiques fondamentales en applications cliniques améliorant la santé humaine reste une entreprise lente, coûteuse et encline à l'échec, malgré les importants progrès de la génétique et de la biologie moléculaire. Les échecs dans le processus de développement des médicaments ont des coûts énormes, dont ceux de causer préjudice à des patients-volontaires et de gaspiller des ressources rares qui pourraient servir à d'autres sphères de recherche plus prometteuses. Afin de comprendre pourquoi tant de médicaments en apparence prometteurs au stade des études précliniques obtiennent de si mauvais résultats lors d'essais cliniques postérieurs, cette thèse élabore une méthode de recherche visant dans un premier temps, à isoler une cohorte de 371 nouveaux agents entrant dans le processus de traduction clinique entre 2000 et 2003, et par la suite, à déterminer l'efficacité pour ces interventions, d'avoir eu accès à des études précliniques effectuées in vivo. De manière générale, on retrouve un important nombre d'études animales publiées dans le domaine (n=2735; 55/agent). Toutefois, le nombre de ces études publiées avant que celles des premières études effectuées sur les humains ne le soient, reste modeste (7/agent). Ceci est particulièrement vrai dans le cas des agents ayant obtenu par la suite, les approbations réglementaires afférentes. Pour les médicaments homologués, on répertoriait en moyenne par agent, la moitié moins d'études animales publiées avant la publication initiale d'essai clinique, que les médicaments non homologués. De plus, 16% des interventions de notre échantillon original n'étaient basées sur aucune donnée animale antérieure que ce soit. Ceci nous laisse croire à une retenue des données tôt dans le processus de développement – surtout peut-être lorsque les espoirs de réussites cliniques sont plus grands. Toutefois, le fait que nous puissions obtenir un grand nombre d'études précliniques laisse supposer qu'il est possible d'effectuer la synthèse des données précliniques afin d'être en mesure de mieux comprendre l'échec de certains médicaments au stade du développement clinique.
Ernest, II Charles. "Benefits of Non-Linear Mixed Effect Modeling and Optimal Design : Pre-Clinical and Clinical Study Applications." Doctoral thesis, Uppsala universitet, Institutionen för farmaceutisk biovetenskap, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-209247.
Full textMy name should be listed as "Charles Steven Ernest II" on cover.
George, Joyce S. M. Massachusetts Institute of Technology. "An ontology model for clinical documentation templates." Thesis, Massachusetts Institute of Technology, 2005. http://hdl.handle.net/1721.1/33845.
Full textIncludes bibliographical references (leaves 46-47).
There are various kinds of clinical documents used in a hospital or clinic setting. With the emergence of Electronic Medical Records, efforts are being made to computerize these documents in a structured fashion in order to enable decision support. With structured data entry, because each fact about the patient is stored discretely and can be retrieved separately, information can be organized and presented in different ways, depending on the needs of the user. A typical structured clinical document contains a range of findings recorded by a physician, nurse or other care. These findings can be thought of as discrete pieces of information, called observations. These observations can be grouped together to form observation sets that can be placed under relevant headers within the document. When building information systems that support structured clinical documentation, these observations and sets are created and stored in catalogs. My thesis addresses the issue of building an ontology model for clinical documentation that supports the creation and management of an observations catalog, observation sets catalog and a clinical document catalog. The ontology can be used as an organizational tool for efficient maintenance of these catalogs. By tagging observations and observation sets with relevant attributes, it is possible to generate intelligent displays of data that are more flexible and dynamic.
by Joyce George.
S.M.
Clokie, Cameron M. L. (Cameron Malcolm Lang). "The titanium-bone interface : a clinical and morphological analysis of osseointegration." Thesis, McGill University, 1992. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=39399.
Full textCopeland, Aquanetta D. "A qualitative study of clinical oncology nurses' perceptions of work-life balance." Thesis, University of Phoenix, 2014. http://pqdtopen.proquest.com/#viewpdf?dispub=3583280.
Full textThe purpose of the hermeneutic phenomenological study was to explore the perceptions and lived-experience of work-life balance of oncology nurses living the Houston Metropolitan area. The two theories used to advance the study were work-family conflict and role stress theory. A single research question guided the study: How do oncology nurses perceive and describe the lived-experience of work-life balance? Twelve oncology nurses were interviewed to identify perceptions of work-life balance, understand from the nurses’ perspectives of the contribution of oncology work environment to work-life balance, to describe the experience of work-life balance, and to identify personal strategies that help the nurses achieve work-life balance. The study revealed nine major themes: (a) work-life balance is described as managing time between work and home; (b) time management and emotional demand are challenges oncology nurses face in achieving work-life balance; (c) the oncology work-environment creates challenges for nurses achieving work-life balance; (d) work-life imbalance creates negative effects for the nurse, the workplace, and the patient; (e) nurses had considered leaving oncology or the current nursing workplace because of work-life balance issues; (f) successful work-life balance has positive outcomes for employees and the workplace employer; (g) A nurses’ lifestyle and demographic factors contributes to successful work-life balance; (h) an organization’s benefits and resources contribute to successful work-life balance; and (i) self-care is a strategy nurses find useful for obtaining and maintaining work-life balance and self-care is important to psychosocial health. Recommendations include providing more staff recognition opportunities, providing more work-life balance resources, performing work-life balance nursing needs assessment, developing work-life balance programs, developing work-life balance champions, developing nurse caregiver programs, and improving marketing and communication regarding work-life benefits and programs. Education recommendations include educating staff about available work-life balance and self-care programs, increasing the amount of and access to oncology related educational opportunities, incorporating work-life balance and self-care in nursing educational programs, and providing time management learning opportunities designed specifically to address managing critically ill patients and high acuity. Finally, a recommendation for nursing practice is developing strategies that include flexible work schedules and self-scheduling.
Tietjen, Joan Marie. "Loneliness in adults with schizophrenia, affective disorders or without clinical diagnosis." The Ohio State University, 1992. http://rave.ohiolink.edu/etdc/view?acc_num=osu1346957443.
Full textPerez, Leon Andres Alfredo. "A Smartphone-based System for Clinical Gait Assessment." Scholar Commons, 2016. http://scholarcommons.usf.edu/etd/6350.
Full textHamilton, Allison R. "A Clinical Documentation Practice Improvement to Increase Insurance Reimbursement." NSUWorks, 2019. https://nsuworks.nova.edu/hpd_con_stuetd/58.
Full textKisat, Mehreen Teizoon, and Mehreen Teizoon Kisat. "Circulating Mitochondrial and Bacterial DNA as Biomarkers of Sepsis." Thesis, The University of Arizona, 2016. http://hdl.handle.net/10150/621839.
Full textVandayar, Yuvika. "A retrospective investigation of sudden unexpected death in the young investigated at Salt River Mortuary, Cape Town." Master's thesis, Faculty of Health Sciences, 2020. http://hdl.handle.net/11427/33965.
Full textVorster, Nina. "Investigating the views and expectations of pregnant women who undergo genetic counselling for age-related risk of aneuploidy." Master's thesis, Faculty of Health Sciences, 2020. http://hdl.handle.net/11427/33968.
Full textSilva, Gustavo Marísio Bacelar da. "Exploring clinical guidelines and the representation of their clinical statments using openEHR." Dissertação, 2012. https://repositorio-aberto.up.pt/handle/10216/72960.
Full textSilva, Gustavo Marísio Bacelar da. "Exploring clinical guidelines and the representation of their clinical statments using openEHR." Master's thesis, 2012. https://repositorio-aberto.up.pt/handle/10216/72960.
Full textHernandez, Maria-Elena. "Visualization for seeking and comparing clinical trials." Thesis, 2009. http://hdl.handle.net/1828/2006.
Full textBasílio, Francisco José Andrade. "Clinical and Forensic Aspects of Pharmacobezoars." Master's thesis, 2020. https://hdl.handle.net/10216/128929.
Full textBackground: Pharmacobezoars are specific types of bezoars formed when medicines, such as tablets, suspensions, and/or drug delivery systems, aggregate and may cause death by occluding airways with tenacious material or by eluting drugs resulting in toxic or lethal blood concentrations. Objective: This work aims to fully review the state-of-the-art regarding pathophysiology, diagnosis, treatment and other relevant clinical and forensic features of pharmacobezoars. Results: Patients of a wide range of ages and in both sexes present with signs and symptoms of intoxications or more commonly gastrointestinal obstructions. The exact mechanisms of pharmacobezoar formation are unknown but is likely multifactorial. The diagnosis and treatment depend on the gastrointestinal segment affected and should be personalized to the medication and the underlying factor. A good and complete history, physical examination, image tests, upper endoscopy and surgery through laparotomy of the lower tract are useful for diagnosis and treatment. Conclusion: Pharmacobezoars are rarely seen in clinical and forensic practice. They are related to controlled or immediate-release formulations, liquid or non-digestible substances, in normal or altered digestive motility/anatomy tract, and in overdoses or therapeutic doses, and should be suspected in the presence of risk factors or patients taking drugs which may form pharmacobezoars.
Basílio, Francisco José Andrade. "Clinical and Forensic Aspects of Pharmacobezoars." Dissertação, 2020. https://hdl.handle.net/10216/128929.
Full textBackground: Pharmacobezoars are specific types of bezoars formed when medicines, such as tablets, suspensions, and/or drug delivery systems, aggregate and may cause death by occluding airways with tenacious material or by eluting drugs resulting in toxic or lethal blood concentrations. Objective: This work aims to fully review the state-of-the-art regarding pathophysiology, diagnosis, treatment and other relevant clinical and forensic features of pharmacobezoars. Results: Patients of a wide range of ages and in both sexes present with signs and symptoms of intoxications or more commonly gastrointestinal obstructions. The exact mechanisms of pharmacobezoar formation are unknown but is likely multifactorial. The diagnosis and treatment depend on the gastrointestinal segment affected and should be personalized to the medication and the underlying factor. A good and complete history, physical examination, image tests, upper endoscopy and surgery through laparotomy of the lower tract are useful for diagnosis and treatment. Conclusion: Pharmacobezoars are rarely seen in clinical and forensic practice. They are related to controlled or immediate-release formulations, liquid or non-digestible substances, in normal or altered digestive motility/anatomy tract, and in overdoses or therapeutic doses, and should be suspected in the presence of risk factors or patients taking drugs which may form pharmacobezoars.